Related Experiment Video
Updated: Oct 2, 2025
09:14
Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
2.5K
Diffuse Alveolar Hemorrhage: An Unexpected Effect After Taking Acetylsalicylic Acid
Mariana M Gomes1, Carolina Barros1, Helena Luís1
1Internal Medicine, Hospital Central do Funchal - Serviço de Saúde da Região Autónoma da Madeira, Entidade Pública Empresarial da Região Autónoma da Madeira (SESARAM, EPERAM), Funchal, PRT.
Cureus
|February 28, 2022
Summary
Prolonged high-dose aspirin use can lead to diffuse alveolar hemorrhage, a rare but serious lung bleeding condition. Clinicians should consider this risk in patients with unexplained pulmonary symptoms after extended aspirin therapy.
Area of Science:
- Pulmonary Medicine
- Hematology
- Toxicology
Background:
- Diffuse alveolar hemorrhage (DAH) is a critical condition often linked to autoimmune diseases, infections, or certain medications.
- Pulmonary hemorrhage presents a diagnostic challenge, requiring prompt identification of underlying causes.
Observation:
- A 45-year-old male presented with diffuse pulmonary hemorrhage.
- The patient had been taking 500 mg of acetylsalicylic acid daily for a month to manage acute lower back pain.
Findings:
- Prolonged, high-dose acetylsalicylic acid (aspirin) intake was identified as the likely cause of the DAH.
- This case highlights aspirin's potential to induce significant bleeding complications, even in the absence of typical risk factors.
Implications:
- This case underscores the importance of a thorough medication history, including over-the-counter drugs, in patients with unexplained DAH.
- Awareness of aspirin-induced pulmonary hemorrhage is crucial for timely diagnosis and management, potentially preventing severe outcomes.
- Further research into the mechanisms and incidence of drug-induced DAH is warranted.
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
256
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
256
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
390
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
390
01:31Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
455
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
455
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
67
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
67
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
904
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
904
01:24Disorders of Hemostasis
1.3K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.3K